title: Thalidomide treatment for refractory HIV-associated colitis: a case series.
abstract: Thalidomide has been used as a treatment for various human immunodeficiency virus (HIV)-associated and non-HIV-associated illnesses, generally in cases in which inflammatory disease is refractory to standard therapy. Here, we discuss the successful use of thalidomide in 3 patients with severe, idiopathic HIV-associated colitis.
authors.affiliation: Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Manchester, United Kingdom. leann.johnson@pat.nhs.uk
authors.forename: Leann
authors.initials: L
authors.lastname: Johnson
authors.forename: Joseph N
authors.initials: JN
authors.lastname: Jarvis
authors.forename: Edmund G L
authors.initials: EG
authors.lastname: Wilkins
authors.forename: Phillip E
authors.initials: PE
authors.lastname: Hay
mesh_terms: D000328:Adult; D003092:Colitis / Q000188:drug therapy*; D003106:Colon / Q000473:pathology; D003113:Colonoscopy; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007413:Intestinal Mucosa / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide